Download Files:
JAK-IN-35
SKU
HY-18301-Get quote
Category Reference compound
Tags Cancer, Epigenetics;JAK/STAT Signaling;Protein Tyrosine Kinase/RTK;Stem Cell/Wnt, JAK
Products Details
Product Description
– JAK-IN-35 (compound TG46) is a JAK2 inhibitor that canb be used in cancer research[1].
Web ID
– HY-18301
Shipping
– Room temperature
Molecular Formula
– C26H34N6O3S
References
– [1]Wenge Zhu, et al. Combination therapy for treating cancer. Patent WO2018187485A1.
CAS Number
– 936091-15-5
Molecular Weight
– 510.65
SMILES
– O=S(C1=CC=CC(NC2=NC(NC3=CC=C(CN4CCOCC4)C=C3)=NC=C2C)=C1)(NC(C)(C)C)=O
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– JAK
Pathway
– Epigenetics;JAK/STAT Signaling;Protein Tyrosine Kinase/RTK;Stem Cell/Wnt
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.